Factors Associated with Stigma in People with Multiple Sclerosis.
Background: Social stigma is a common experience among persons with multiple sclerosis (PwMS), and it may impact daily functioning, quality...
Gratitude, Perceived Stress, and Quality of Life Among Patients with MS
Background: Multiple sclerosis (MS) is characterized by an unpredictable course of neurological symptoms that are thought to be exacerbated...
Direct Cost Associated with Multiple Sclerosis and Important Components; A Population-Based Study 1997-2017
Direct cost associated with Multiple sclerosis: A Population-Based Study 1997-2017 Background: Multiple sclerosis (MS) is a chronic...
Regional MS Summit to Improve Access to High Quality MS Care
Background: In 2006, the Greater Northwest Healthcare Provider Council (HPC) of the National Multiple Sclerosis Society (NMSS) identified a...
Validating the Clinical Usefulness of the Timed 25-Foot Walk in MS in Routine Clinical Practice
Background: Multiple Sclerosis (MS) is a chronic and degenerative autoimmune disease of the central nervous system which can cause...
RGC-32 Contributes to Reactive Astrocytosis in Experimental Autoimmune Encephalomyelitis By Maintaining a Mature Phenotype
Background: Astrocytes are increasingly recognized as critical contributors to the pathogenesis of multiple sclerosis and experimental...
Clinical and Diagnostic Spectrum of Optic Neuritis: A Single-Center Retrospective Study of Disorders Associated with Multiple Sclerosis, Aquaporin-4 Antibody, and Myelin Oligodendrocyte Glycoprotein Antibody
Background: Optic neuritis (ON) is an immune-mediated optic neuropathy associated with multiple immune-mediated neurological conditions....
Integrated Clinic-Based Pharmacist Impact on Time to Fingolimod Treatment Initiation
Background: Multiple Sclerosis (MS) has no cure and causes irreversible damage to the brain and spinal cord leading to physical and...